20/20 Biolabs, Inc. (AIDX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$0.48

From 52W high−98.05%

Volume28818.00

Market cap$5.94M

P/E (TTM)—

P/S (TTM)2.9x

Div yield—

Key dataSep 18, 2026

Open

$0.48

From 52W high

−98.05%

Volume

28818.00

Market cap

$5.94M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.7x

P/E (TTM)

—

RSI (14)

40.3

MomentumView details →

1D Return

−1.36%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−0.7x

EV/Sales

1.7x

P/S (TTM)

2.9x

P/B (TTM)

1.9x

ProfitabilityView details →

Gross Margin

31.52%

Net Margin

−285.00%

EBITDA Margin

−235.10%

ROE (TTM)

−184.04%

ROA (TTM)

−94.96%

Asset Turnover

0.34x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

−43.03%

EPS CAGR 3Y

+48.28%

EBITDA YoY

—

MomentumView details →

1D Return

−1.36%

YTD Return

—

1Y Return

—

RSI (14)

40.3

vs 50D SMA

−6.43%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.18x

Current Ratio

1.99x

Quick Ratio

1.95x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.26

EPS Surprise

−116.67%

Beats (12Q)

0/12

Next Q EPS Est

−$0.06

Avg Surprise (4Q)

−116.67%

Rev Surprise

14.87%

Financials snapshotView financials →

Revenue (TTM)

2.04M

Net Income (TTM)

−5.81M

Op. CF (TTM)

−2.79M

Latest newsMore news →

Nasdaq notified 20/20 Biolabs, Inc. on September 3, 2026 that it failed to comply with the $2.5 million stockholders' equity requirement under Listing Rule 5550(b)(1), giving the company 45 calendar days to submit a compliance plan.10d ago

BioLabs announced Carmen Schicklberger as site director for BioLabs Rochester, MN, and Geof Hannigan as Mayo Clinic's director of startup engagement.18d ago

Similar companies

enVVeno Medical CorporationNVNO IceCure Medical LtdICCM Bone Biologics CorporationBBLGW Autonomix Medical, Inc. Common StockAMIX Pheton Holdings Ltd Class A Ordinary SharesPTHL Bluejay Diagnostics, Inc.BJDX Find similar companies →

Latest newsMore news →

Nasdaq notified 20/20 Biolabs, Inc. on September 3, 2026 that it failed to comply with the $2.5 million stockholders' equity requirement under Listing Rule 5550(b)(1), giving the company 45 calendar days to submit a compliance plan.10d ago BioLabs announced Carmen Schicklberger as site director for BioLabs Rochester, MN, and Geof Hannigan as Mayo Clinic's director of startup engagement.18d ago BioLabs Rochester, MN announced it will open its 17,000-square-foot shared laboratory and office facility in September 2026, with recruitment underway for resident companies.18d ago